Results 161 to 170 of about 34,651 (222)

Risk of Hospitalized COVID-19 in COPD: Single-Inhaler Triple Versus Dual Bronchodilator Therapy. [PDF]

Pharmacoepidemiol Drug Saf
Galmiche S, Dell'Aniello S, Suissa S.
europepmc   +1 more source

Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: Cohort study [PDF]

, 2019
Al-Aly, Ziyad, Bowe, Benjamin, Li, Tingting, Xian, Hong, Xie, Yan, Yan, Yan   +5 more
core   +1 more source

Recommendations for benefit-risk assessment methodologies and visual representations.

, 2015
Ashby, D, Chan, E, Downey, GF, Goginsky, A, Hallgreen, CE, Hockley, KS, Hughes, D, Juhaeri, J, Lieftucht, A, Metcalf, MA, Micaleff, A, Mt-Isa, S, Noel, RA, Phillips, LD, PROTECT Benefit-Risk Group, Waddingham, E   +15 more
core   +1 more source

Psychiatric adverse events in oseltamivir prophylaxis trials: Novel comparative analysis using data obtained from clinical study reports [PDF]

, 2018
Bender, Doshi, Gravenstein, Hayden, Jefferson, Jefferson, Jones, Lineberry, Patel, Peters, Simmonds, Toovey, Welliver   +12 more
core   +1 more source

Electronic data sources for drug utilization research and healthcare decision-making in Mexico. [PDF]

BMC Health Serv Res
Santa-Ana-Tellez Y, Dreser Mansilla A, Castro Pastrana LI, Salas M, Sánchez Salgado JC, Gómez-Galicia D, Freitas Leal L, Cruz Lopes L.   +7 more
europepmc   +1 more source

Real-World Evidence in Drug Approvals at the European Medicines Agency.

JAMA Netw Open
Bachinger M, Jankowski MA, Kesselheim AS, Krüger N.   +3 more
europepmc   +1 more source

Trends in Medication Use Among Young Adults and the Covid-19 Pandemic Effect. [PDF]

Pharmacoepidemiol Drug Saf
Zur M, Tsur AM, Friedensohn L, Matok I.
europepmc   +1 more source

Correction to: 'Long-term prognostic implications of type 2 diabetes mellitus in colorectal cancer patients'. [PDF]

Colorectal Dis
europepmc   +1 more source

Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management. [PDF]

Pharmacoepidemiol Drug Saf
Norén GN, Donegan K, Muñoz MA, Alshammari TM, Pratt N, Candore G, Morales D, Rijnbeek P, Bate A, Postigo R, Toh S, Trifirò G, Gabarro MS, Cave A, Ryan PB.   +14 more
europepmc   +1 more source

Correction: Major Adverse Cardiovascular Events Related to JAK Inhibitors: A Disproportionality Analysis Using the WHO Global Individual Case Safety Database. [PDF]

Drug Saf
Di Napoli R, Richez C, Scavone C, Singier A, Demourgues M, Mascolo A, Capuano A, Salvo F.   +7 more
europepmc   +2 more sources